Revenue YoY
—
Operating Income YoY
+41.38%
Net Income YoY
+32.90%
Net Margin Δ
—
Net income bridge for Spruce Biosciences (SPRB) — TTM through Q1 2026 vs TTM through Q1 2025
Δ Net income: $18.26M+32.90%
Profit bridge breakdown for Spruce Biosciences (SPRB) — TTM through Q1 2026 vs TTM through Q1 2025
| Driver | Contribution | % of Δ |
|---|---|---|
| Prior Net Income | −$55.45M | — |
| Revenue | −$2.91M | -15.9% |
| Cost of Revenue | $0.00 | 0.0% |
| Operating Expenses | $26.91M | +147.4% |
| Other Income / Expense | −$5.74M | -31.4% |
| Income Tax | $0.00 | 0.0% |
| Net Loss | −$37.19M | — |
- Prior Net Income−$55.45M
- Revenue−$2.91M
- Cost of Revenue$0.00
- Operating Expenses$26.91M
- Other Income / Expense−$5.74M
- Income Tax$0.00
- Net Loss−$37.19M
Identity check: drivers reconcile to ΔNI within $0.00 ✓
Want the full P&L structure?Income Statement Waterfall
Frequently asked questions
Data & methodology
Spruce Biosciences (SPRB) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement